Crossref
269 Risk vs. Reward: Long-Term Stimulant Therapy in Adults with ADHD
Journal of the American Pharmacists Association · 2026-07 · 66 (4) · 103295
DOI: 10.1016/j.japh.2026.103295 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Pharmacists Association, 2026-07. Verfasst von J. Vo und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Vo, J., Vigilante, D., Yao, G., & Dopheide, J. (2026). 269 Risk vs. Reward: Long-Term Stimulant Therapy in Adults with ADHD. Journal of the American Pharmacists Association, 66(4), 103295. https://doi.org/10.1016/j.japh.2026.103295
Vancouver
Vo J, Vigilante D, Yao G, Dopheide J. 269 Risk vs. Reward: Long-Term Stimulant Therapy in Adults with ADHD. Journal of the American Pharmacists Association. 2026;66(4):103295. doi:10.1016/j.japh.2026.103295
BibTeX
@article{Vo2026,
author = {Vo, J. and Vigilante, D. and Yao, G. and Dopheide, J.},
title = {269 Risk vs. Reward: Long-Term Stimulant Therapy in Adults with ADHD},
journal = {Journal of the American Pharmacists Association},
year = {2026},
volume = {66},
number = {4},
pages = {103295},
doi = {10.1016/j.japh.2026.103295}
}
EUVIMED